Event Brief
Stopping GLP-1 drugs erodes heart health benefits
Filed: Mar 24, 2026 at 8:02 AM ET
Summary: A new study finds that stopping GLP-1 drugs like Ozempic raises cardiovascular risk by 22% within two years.
WHO: Researchers
WHAT: Study on the effects of stopping GLP-1 drugs
WHEN: Mar 24, 2026 at 7:00 AM ET
WHERE: USA
WHY: To investigate the cardiovascular risks associated with discontinuing GLP-1 medications.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →